Home/Filings/4/0001140361-16-059864
4//SEC Filing

AFFYMETRIX INC 4

Accession 0001140361-16-059864

CIK 0000913077operating

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 5:34 PM ET

Size

24.0 KB

Accession

0001140361-16-059864

Insider Transaction Report

Form 4
Period: 2016-03-31
Wood Gavin
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-3125,0000 total
    Exercise: $11.88Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-3135,0000 total
    Exercise: $7.55Common Stock (35,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-3122,0000 total
    Exercise: $3.77Common Stock (22,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-315,0000 total
    Exercise: $4.16Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-318,0000 total
    Exercise: $3.77Common Stock (8,000 underlying)
  • Disposition to Issuer

    Performance RSUs

    2016-03-3126,5040 total
    Exercise: $0.00Common Stock (26,504 underlying)
  • Disposition to Issuer

    Common Stock

    2016-03-31137,5730 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-3167,5000 total
    Exercise: $5.57Common Stock (67,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-314,0000 total
    Exercise: $4.85Common Stock (4,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2016-03-315,0000 total
    Exercise: $3.91Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]Includes 456 shares purchased by Mr. Wood through our Employee Stock Purchase Plan on March 14, 2016.
  • [F2]Pursuant to the Agreement and Plan of Merger dated as of January 8, 2016 by and among Affymetrix, Inc. ("Affymetrix"), Thermo Fisher Scientific Inc. ("Thermo Fisher") and White Birch Merger Co. (the "Merger Agreement"), (x) each outstanding share of common stock of Affymetrix was cancelled and converted into the right to receive $14.00 in cash; (y) each vested stock option was cancelled and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price; and (z) each unvested stock option and RSU (including PRSUs at target), whether vested or unvested, was assumed by Thermo Fisher and converted into the right to receive a cash payment per share equal to the excess, if any, of $14.00 over the exercise price, as applicable.

Documents

1 file

Issuer

AFFYMETRIX INC

CIK 0000913077

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000913077

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:34 PM ET
Size
24.0 KB